Summary The relationship between tumour growth, insulin status, blood lipids and adipose linoleic acid (LA, reflecting long-term LA intake) was studied in 19 Jewish women suffering from early and advanced stages (ES and AS) of ovarian and endometrial tumours. Blood insulin in patients with ES tumours was four times higher than the control value in cancer-free subjects, but fell to normal levels at AS and after ES surgery (PES) . Tumours The involvement of insulin as a growth factor or anabolic hormone has been reviewed recently (Yam, 1992) . Among dietary factors, evidence obtained in animals as well as in humans suggests that LA increases the incidence, growth and metastasis of tumours (Hubbard & Erikson, 1987) and leads to hyperinsulinaemia and insulin resistance (Lardinois et al., 1987) . Conflicting observations have been reported regarding blood cholesterol and its possible relationship to cancer (Fernleib, 1983) .
In order to obtain more information on the relationship between tumour growth, insulin status, blood lipids and long-term linoleic acid intake, we examined women suffering from ovarian and endometrial tumours at ES and AS. This work forms part of an ongoing study in which a larger number of patients are being examined. The fatty acid concentration of LA in cancer patients was significantly lower than in controls (20.5 ± 3.7 vs 26.4 ± 1.5). This was compensated by an increase in palmitic acid (21.6 ± 2.3 vs 17.7 ± 2.2). There were no significant differences in storage fatty acids.
Discussion
The considerable hyperinsulinaemia seen in our tumourbearing patients may be caused by a combination of several factors: (a) impaired insulin metabolism as seen in obesity; (b) high consumption of LA (Lardinois et al., 1987) ; (c) insulin secretion by insulin-producing/secreting tumours (Yam, 1992) ; and (d) enhanced secretion of insulin by B cells of the patient's pancreas induced by the tumour, presumably via some messenger (Pavelic & Slijepcevic, 1978) . Hyperinsulinaemia and insulin-like substances and insulin resistance have been reported by Berstein et al. (1985) and Copeland et al. (1987) . Hyperinsulinaemia may evoke a down-regulation of insulin receptors in normal but not cancerous cells (Mountjoy et al., 1987) , conferring on the latter serious advantages in growth.
Of particular interest are the data on the SAT fatty acid composition. These data show (a) that long-term LA intake is very high in Israeli Jews, in agreement with earlier reports (Berry et al., 1986) and (b) that our cancer patients had less LA than the controls in SAT. The lower LA content of cancer patients may reflect either a reduced long-term LA intake or possibly an increased mobilisation of this fatty acid for providing structural (e.g. arachidonic acid) and functional elements (e.g. PGE2) involved in tumour development and immunosuppression (Hubbard & Erikson, 1987; Karmali, 1987) .
High consumption of LA has been reported to cause hyperinsulinaemia and insulin resistance (Lardinois et al., 1987) and may be the cause for the high prevalence of glucose intolerance observed by Modan et al. (1985) in Israeli Jews. Bitterman et al. (1991) reported a significantly greater prevalence of urological cancer morbidity in Acre (Israel) as compared with non-Jews. A similar trend of other cancers was reported by the Israel Ministry of Health (1992) . The present results on blood lipids, especially the rise in CHOL and LDL in ES patients, and the subsequent drop at AS, do not permit conclusions regarding the role of blood cholesterol in cancer. It is possible that, since cholesterol metabolism is profoundly affected by insulin (Stolar, 1988) , abnormal blood cholesterol in tumour-bearing subjects may be secondary to abnormal insulin regulation and metabolism in malignancies.
Additional data may reinforce our interpretation and avoid possible biases because of the small number of cases.
